MedPath

MedImmune Ltd.

🇬🇧United Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.medimmune.com

A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis

Phase 1
Completed
Conditions
Rheumatoid Arthritis
Interventions
Other: Placebo
First Posted Date
2008-10-13
Last Posted Date
2012-07-20
Lead Sponsor
MedImmune Ltd
Target Recruit Count
38
Registration Number
NCT00771420
Locations
🇩🇪

Charite Research Organization GmbH, Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath